1
|
González CGR, Vega ECD, Martínez SDLV, Minero MV, Urbón JMG, Manzorro ÁG, Martínez EFDG, Sacristán SC, Santiago EB, Alonso AH, Paredes PMGD, Sáez MS. A critical view on the current use of daptomycin in Spain: The daptomise study. J Infect Public Health 2023; 16:1115-1122. [PMID: 37220712 DOI: 10.1016/j.jiph.2023.05.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Revised: 04/20/2023] [Accepted: 05/07/2023] [Indexed: 05/25/2023] Open
Abstract
BACKGROUND The Study on the Clinical Use of DAPTOMycin in Spain (DAPTOMISE Study) is a national surveillance program of daptomycin use. The objectives of this study are to evaluate the current variability in daptomycin consumption across the different hospitals and the adequacy of therapy, specially focused on underdosing. METHODS All adult and pediatric patients who received, at least, one dose of daptomycin in a single week in 98 institutions in Spain were included. The adequacy of daptomycin use was evaluated with respect to the indication, dosage, adjustments after microbiology results, switching to an oral agent and length of treatment. RESULTS A total of 615 patients received daptomycin during the study week. The prevalence use was 2.3 patients / 100,000 inhabitants per week, 12.4 patients / 1000 admissions and 9.2 Days of Therapy (DOT) / 1000 hospital stays. These rates varied between hospitals: from 0 to 13.9 patients / 100,000 inhabitants, from 0 to 76.1 patients / 1000 admissions and from 0 to 49.4 DOT / 1000 hospital stays. The most frequent infections were bacteremia (31.6 %) and skin and soft tissue infections (17.9 %). Microbiological results were available in only 65.4 % of infections. The most frequent microorganisms were Staphylococcus aureus (192 isolates, of which 87 were resistant to methicillin) and coagulase-negative staphylococci (124 isolates). A total of 136 prescriptions (22.1 %) were underdosed. Dosages < 8 mg/kg were used for 35.6 % of endovascular infections and for 26.2 % of osteoarticular infections. Overall, 57.2 % of prescriptions were not optimal in, at least, one item. Clinical cure rate was 76.1% and mortality attributable to the infection 8.1%. CONCLUSION This is the first registry that identifies the prevalence of use of daptomycin in Spain and shows a high variability in the consumption between the different hospitals. Daptomycin underdosing was present in more than 20 % of cases.
Collapse
Affiliation(s)
- Carmen Guadalupe Rodríguez González
- Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
| | - Esther Chamorro de Vega
- Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| | - Sofía De la Villa Martínez
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Maricela Valerio Minero
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
| | | | - Álvaro Giménez Manzorro
- Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| | | | - Sara Cobo Sacristán
- Pharmacy Department. Hospital Universitari de Bellvitge, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain
| | - Emilio Bouza Santiago
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; CIBER Enfermedades Respiratorias, CIBERES (CB06/06/0058), Madrid, Spain
| | - Ana Herranz Alonso
- Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| | - Patricia Muñoz García de Paredes
- Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Medicine Department, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain; CIBER Enfermedades Respiratorias, CIBERES (CB06/06/0058), Madrid, Spain
| | - María Sanjurjo Sáez
- Pharmacy Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| |
Collapse
|
2
|
González Guembe M, Tisner Pensado Y, Tejerina Picado F, Diez C, Pérez Latorre L, Fanciulli C, Parras Vázquez F, López Bernaldo de Quirós JC, Berenguer J, Padilla Ortega B, Machado M, Valerio Minero M, Muñoz Garcia P, Bouza Santiago E, Galar A, Catalan P, Alonso R, Bellón JM, Aldámiz-Echevarría Lois T, (Javier) AJ, (Luis) A, (Teresa) A, (Roberto) A, (Beatriz) Á, (Ana) ÁU, (Alexi) A, (Luis Antonio) A, (Juan) B, (Elena) B, (Emilio) B, (Almudena) B, (Ana) C, (Raquel) C, (Pilar) C, (Emilia) C, (Alejandro) C, (Cristina) D, (Pilar) E, (Agustín) E, (Chiara) F, (Alicia) G, (Ma Dolores) G, (Darío) GDV, (Paloma) G, (Adolfo) G, (Helmuth) G, (Jesús) G, (Laura Vanessa) H, (Marta) H, (Martha) K, (Juan Carlos) L, (Carmen Narcisa) L, (Marina) M, (Mercedes) M, (Pablo) M, (Pedro) M, (Zaira) M, (Patricia) M, (María) O, (Belén) P, (María) P, (Francisco) P, (María Jesús) PG, (Laura) PL, (Leire) P, (Paula) P, (Sandra) RM, (Elena) R, (Cristina) R, (Belén) R, (Sara) R, (Cristina) RG, (Adriana) R, (María Jesús) RS, (Carlos) S, (Mar) S, (Julia) S, (Pedro J) SC, (Francisco) T, (Maricela) V, (Ma Cristina) V, (Lara) V, (Teresa) V, (Sofía) ADLV. SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid. AIDS Res Hum Retroviruses 2022; 38:394-398. [PMID: 34969259 DOI: 10.1089/aid.2021.0159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Since SAR-COV-2 infection emerged and spread worldwide, little is known about its impact on people living with human immunodeficiency virus (HIV). We performed a single-center retrospective study to describe the potential particularities and risk factors for respiratory failure (RF) in that population. This single-center retrospective study included patients infected with HIV, whose current follow-up is run in this center, above18 years of age, with diagnosis of SARS-CoV-2 infection between March 5, 2020 and April 15, 2021. We collected data regarding HIV immunological and virological status, main epidemiological characteristics, as well as those conditions considered to potentially influence in SARS-CoV-2 evolution; and clinical, microbiological, radiological, respiratory status, and survival concerning coronavirus disease 2019 (COVID-19). We compared all that, for patients with and without RF and performed a logistic regression for suspected risk factors for RF. One hundred seventy-seven HIV patients were diagnosed from COVID-19 (mean age 53.8 years, 81.3% male). At diagnosis, 95.5% were receiving ART and 91.3% had undetectable viral load, with median CD4 count of 569 cells/μL. One hundred thirty-eight patients (78.4%) had symptoms, 44 (25%) developed RF and 53 (31%) developed bilateral pneumonia. The most commonly used treatments were: steroids (26.7%) and hydroxychloroquine (13.1%). When comparing patients with and without RF, we found statistically significant differences for 20 of the analyzed variables such as age (p < .001) and CD4 (p 0.002), and route of HIV transmission by intravenous drug users IVDU (p 0.002) were determined. In multivariate analysis, age [odds ratio (OR) 1.095] and CD4 count less than 350 cells/μL (OR 3.36) emerged as risk factor for RF. People living with HIV whose CD4 count is <350 cells are at higher risk of developing RF when infected by SARS-CoV-2.
Collapse
Affiliation(s)
| | | | - Francisco Tejerina Picado
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Cristina Diez
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Leire Pérez Latorre
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Chiara Fanciulli
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Francisco Parras Vázquez
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Juan Carlos López Bernaldo de Quirós
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Juan Berenguer
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Belen Padilla Ortega
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Marina Machado
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Maricela Valerio Minero
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Patricia Muñoz Garcia
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Emilio Bouza Santiago
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Alicia Galar
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Pilar Catalan
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Roberto Alonso
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Jose M Bellón
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | - Teresa Aldámiz-Echevarría Lois
- Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain
- Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Fernández-Cruz A, Muñoz P, Sandoval C, Fariñas C, Gutiérrez-Cuadra M, Pericás Pulido JM, Miró JM, Goenaga-Sánchez MÁ, de Alarcón A, Bonache-Bernal F, Rodríguez M, Noureddine M, Bouza Santiago E. Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm?: A prospective, multicenter cohort. Medicine (Baltimore) 2017; 96:e7913. [PMID: 28930826 PMCID: PMC5617693 DOI: 10.1097/md.0000000000007913] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
The aim of the study was to draw a comparison between the characteristics of infective endocarditis (IE) in patients with cancer and those of IE in noncancer patients.Patients with IE, according to the modified Duke criteria, were prospectively included in the GAMES registry between January 2008 and February 2014 in 30 hospitals. Patients with active cancer were compared with noncancer patients.During the study period, 161 episodes of IE fulfilled the inclusion criteria. We studied 2 populations: patients whose cancer was diagnosed before IE (73.9%) and those whose cancer and IE were diagnosed simultaneously (26.1%). The latter more frequently had community-acquired IE (67.5% vs 26.4%, P < .01), severe sepsis (28.6% vs 11.1%, P = .013), and IE caused by gastrointestinal streptococci (42.9% vs 16.8%, P < .01). However, catheter source (7.1% vs 29.4%, P = .003), invasive procedures (26.2% vs 44.5%, P = .044), and immunosuppressants (9.5% vs 35.6%, P = .002) were less frequent.When compared with noncancer patients, patients with cancer were more often male (75.2% vs 67.7%, P = .049), with a higher comorbidity index (7 vs 4). In addition, IE was more often nosocomial (48.7% vs 29%) and originated in catheters (23.6% vs 6.2%) (all P < .01). Prosthetic endocarditis (21.7% vs 30.3%, P = .022) and surgery when indicated (24.2% vs 46.5%, P < .01) were less common. In-hospital mortality (34.8% vs 25.8%, P = .012) and 1-year mortality (47.8% vs 30.9%, P < .01) were higher in cancer patients, although 30-day mortality was not (24.8% vs 19.3%, P = .087).A significant proportion of cases of IE (5.6%) were recorded in cancer patients, mainly as a consequence of medical interventions. IE may be a harbinger of occult cancer, particularly that of gastrointestinal or urinary origin.
Collapse
Affiliation(s)
- Ana Fernández-Cruz
- Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid
- Instituto de Investigación Sanitaria Gregorio Marañón
| | - Patricia Muñoz
- Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid
- Instituto de Investigación Sanitaria Gregorio Marañón
- CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058)
- Facultad de Medicina, Departamento de Medicina, Universidad Complutense de Madrid
| | - Carmen Sandoval
- Instituto de Investigación Sanitaria Gregorio Marañón
- Department of Oncology, Hospital General Universitario Gregorio Marañón, Madrid
| | - Carmen Fariñas
- Department of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander
| | - Manuel Gutiérrez-Cuadra
- Department of Infectious Diseases, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander
| | - Juan M. Pericás Pulido
- Infectious Diseases Service, Hospital Clinic-IDIBAPS, Universitat de Barcelona, Barcelona
| | - José M. Miró
- Infectious Diseases Service, Hospital Clinic-IDIBAPS, Universitat de Barcelona, Barcelona
| | | | - Arístides de Alarcón
- Department of Infectious Diseases, Hospital Universitario Virgen del Rocío, Sevilla
| | | | - MªÁngeles Rodríguez
- Department of Infectious Diseases, Hospital Universitario Central de Asturias, Oviedo
| | - Mariam Noureddine
- Department of Infectious Diseases, Hospital Costa del Sol, Marbella, Spain
| | - Emilio Bouza Santiago
- Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid
- Instituto de Investigación Sanitaria Gregorio Marañón
- CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058)
- Facultad de Medicina, Departamento de Medicina, Universidad Complutense de Madrid
| |
Collapse
|
4
|
Alcalá Hernández L, Reigadas Ramírez E, Bouza Santiago E. Infección por Clostridium difficile. Med Clin (Barc) 2017; 148:456-463. [DOI: 10.1016/j.medcli.2017.01.033] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2016] [Revised: 01/22/2017] [Accepted: 01/29/2017] [Indexed: 12/17/2022]
|
5
|
Goenaga Sánchez MÁ, Kortajarena Urkola X, Bouza Santiago E, Muñoz García P, Verde Moreno E, Fariñas Álvarez MC, Teira Cobo R, Pericás Pulido JM, de Alarcón González A, Sousa Regueiro D, Ruiz Morales J, Rodríguez-Álvarez RJ, Antorrena Miranda I, Iribarren Loyarte JA. Aetiology of renal failure in patients with infective endocarditis. The role of antibiotics. Med Clin (Barc) 2017; 149:331-338. [PMID: 28431897 DOI: 10.1016/j.medcli.2017.03.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Revised: 02/23/2017] [Accepted: 03/02/2017] [Indexed: 11/26/2022]
Abstract
BACKGROUND AND OBJECTIVES The possible renal toxicity of certain antibiotics (AB) is well known. The objective of our work is to know the possible effect of AB treatments in the development of renal failure (RF) in patients with infective endocarditis (IE). MATERIAL AND METHOD Collection from a national multi-centre registry of collection on renal function, both prior and its impairment, if any, during the treatment of IE and in relation to possible causative factors, including the use of AB. RESULTS Between 2008 and 2012, 1,853 episodes of IE reported from 26 Spanish centres were analysed. Of these, 21.6% had prior RF. They developed new RF or impairment of renal function in 38.7% of the cases. In patients with prior RF, impairment was more frequent (64 vs. 31.7%, P<.001). Overall, patients with RF were older (70.6 vs. 67 years, P<.01), had more comorbidities (Charlson index 5 vs. 4, P<.01), and IE by Staphylococcus aureus (32.1 vs. 16.5%, P<.01). Potentially nephrotoxic AB use was only associated with RF in patients without prior RF (aminoglycosides: OR=1.47 [95% CI 1.096-1.988], P=.010; aminoglycosides with vancomycin: OR=1.49 [95% CI 1.069-2.09], P=.019). CONCLUSIONS In patients without prior RF, the use of nephrotoxic AB is associated with impairment of renal function. In patients with RF prior to the IE episode, impairment of renal function was more frequent but appears to be more related to the severity of infection.
Collapse
Affiliation(s)
| | - Xabier Kortajarena Urkola
- Servicio de Enfermedades Infecciosas, Hospital Universitario Donostia, San Sebastián, Guipúzcoa, España
| | - Emilio Bouza Santiago
- Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) (CB06/06/0058), Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
| | - Patricia Muñoz García
- Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) (CB06/06/0058), Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España
| | - Eduardo Verde Moreno
- Servicio de Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, España
| | - M Carmen Fariñas Álvarez
- Servicio de Enfermedades Infecciosas, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, España
| | - Ramón Teira Cobo
- Servicio de Medicina Interna, Hospital Sierrallana, Torrelavega, Santander, España
| | - Juan Manuel Pericás Pulido
- Servicio de Enfermedades Infecciosas, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, España
| | - Arístides de Alarcón González
- Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine Infectious Diseases Research Group, Institute of Biomedicine of Seville (IBIS), University of Seville/CSIC/University Virgen del Rocío and Virgen Macarena, Sevilla, España
| | - Dolores Sousa Regueiro
- Servicio de Enfermedades Infecciosas, Complejo Hospitalario Universitario de A Coruña, A Coruña, España
| | - Josefa Ruiz Morales
- Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospital Clínico Universitario Virgen de la Victoria, Málaga, España
| | | | | | | | | |
Collapse
|
6
|
Santiago EB, Garau J, Crespo RZ, Gonzalo de Liria CR. [Relationships with microbiology: the view from other specialties]. Enferm Infecc Microbiol Clin 2011; 28 Suppl 3:39-44. [PMID: 21129585 DOI: 10.1016/s0213-005x(10)70018-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The major advances produced in infectious diseases, partly favored by technological development in the last few years, together with current changes in healthcare, have led to a new scenario in which, far from the control of infectious diseases, clinical microbiology has acquired an undoubted leading role. This new panorama implies collaboration among distinct health professionals within the same healthcare setting, with common and occasionally conflicting interests. Setting aside the individual differences that can be produced in the daily life of our hospitals, all health professionals should understand one another, not only because such cooperation is required for optimal patient care but also because synergistic collaboration among professions would improve professional development. Based on this principle of a multidisciplinary approach, collaboration and mutual respect, the moment seems opportune for the various professionals involved in infectious diseases (infectologists, internists, pediatricians and intensivists) to express their view of the specialty of clinical microbiology. The present article includes reflections, from a highly liberal and personal point of view, on how mutual relationships can be approached and on how greater knowledge of infectious diseases can continue to be gained in Spain. In all these reflections, the questions of where we come from and where we are going are explicit or implicit.
Collapse
Affiliation(s)
- Emilio Bouza Santiago
- Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, España.
| | | | | | | |
Collapse
|
7
|
González Ramallo VJ, Bouza Santiago E. [Home intravenous antimicrobial therapy]. Med Clin (Barc) 2008; 131:295-297. [PMID: 18803924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
|
8
|
González Ramallo VJ, Bouza Santiago E. Tratamiento antimicrobiano intravenoso en el domicilio. Med Clin (Barc) 2008. [DOI: 10.1157/13125793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
9
|
|
10
|
Santiago EB. Farewell Message from the Editor-in-Chief. Clin Microbiol Infect 2003. [DOI: 10.1111/j.1469-0691.2003.00810.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Romão N, Drumond Neto C, Santiago EB, Rodrigues CV, Soares RV, Lopes KW, Reis NB. [Cardiac performance in acute aortic insufficiency]. Arq Bras Cardiol 1980; 34:211-6. [PMID: 7436779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
|
12
|
Romão N, Rodrigues CM, Santiago EB, Drumond Neto C, Lopes KW, Soares RV, Reis NB. [Cardiac performance in acute mitral insufficiency]. Arq Bras Cardiol 1980; 34:13-8. [PMID: 7406735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
|
13
|
Romão N, Santiago EB, Rodrigues CV, Drumond Neto C, Santos MDL, Soares RV, Santos MA, Reis NB. [Left ventricular performance in the right ventricular overload]. Arq Bras Cardiol 1979; 33:407-13. [PMID: 550778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
|